Furthermore, auranofin, a thioredoxin inhibitor that is used to treat rheumatoid arthritis [36], inhibits Janus kinase 1 (JAK1)/STAT3 phosphorylation [37,38]. This evidence concerns the gene JAK1 and rheumatoid arthritis.